Franklin Resources’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-803,339
| Closed | -$14.1M | – | 2599 |
|
|
2021
Q3 | $14.1M | Sell |
803,339
-2,921,896
| -78% | -$34.1M | 0.01% | 972 |
|
|
2021
Q2 | $36.1M | Buy |
3,725,235
+251,830
| +7% | +$2.37M | 0.01% | 732 |
|
|
2021
Q1 | $37.3M | Buy |
3,473,405
+26,271
| +0.8% | +$325K | 0.02% | 697 |
|
|
2020
Q4 | $50.7M | Buy |
3,447,134
+665,694
| +24% | +$9.6M | 0.02% | 589 |
|
|
2020
Q3 | $39.5M | Buy |
2,781,440
+1,266,540
| +84% | +$12.6M | 0.02% | 615 |
|
|
2020
Q2 | $12.4M | Hold |
1,514,900
| – | – | 0.01% | 828 |
|
|
2020
Q1 | $6.12M | Buy |
+1,514,900
| New | +$5.73M | ﹤0.01% | 896 |
|
|
2017
Q3 | – | Sell |
-20,200
| Closed | -$89K | – | 1528 |
|
|
2017
Q2 | $89K | Sell |
20,200
-374,800
| -95% | -$2.07M | ﹤0.01% | 1488 |
|
|
2017
Q1 | $2.44M | Hold |
395,000
| – | – | ﹤0.01% | 1220 |
|
|
2016
Q4 | $2.23M | Hold |
395,000
| – | – | ﹤0.01% | 1214 |
|
|
2016
Q3 | $5.84M | Hold |
395,000
| – | – | ﹤0.01% | 1077 |
|
|
2016
Q2 | $3.55M | Hold |
395,000
| – | – | ﹤0.01% | 1154 |
|
|
2016
Q1 | $3.65M | Hold |
395,000
| – | – | ﹤0.01% | 1154 |
|
|
2015
Q4 | $4.98M | Hold |
395,000
| – | – | ﹤0.01% | 1133 |
|
|
2015
Q3 | $5.15M | Hold |
395,000
| – | – | ﹤0.01% | 1139 |
|
|
2015
Q2 | $8.62M | Buy |
+395,000
| New | +$9.01M | ﹤0.01% | 1069 |
|
Other funds holding TRIL
Franklin Resources's TRIL Position: Q4 2021 in Review
Franklin Resources sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 803,339 shares — an estimated $14.1M sold.
Franklin Resources first reported a position in TRIL in Q2 2015 and held it in 16 quarters. The position peaked at $50.7M in Q4 2020. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.
- Franklin Resources reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
- Franklin Resources sold 803,339 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $14.1M.
- Franklin Resources first reported a position in Trillium Therapeutics Inc. in Q2 2015 and held it in 16 quarters.
- Franklin Resources's Trillium Therapeutics Inc. position peaked at $50.7M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.
Based on Franklin Resources's 13F filing for Q4 2021, filed 11 Feb 2022.